Patient Risk Stratification Market Outlook 2026–2035 Driven by Key Growth Factors and Industry Projections
The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Much Is The Patient Risk Stratification Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?
Recently, the patient risk stratification market has seen its size increase dramatically. Projections indicate it will expand from $2.81 billion in 2025 to $3.68 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 31.0%. Historically, this growth has been influenced by factors including manual patient risk assessments, a significant reliance on historical patient data, fragmented healthcare information systems, the limited application of predictive analytics, and an absence of standardized risk models.
The patient risk stratification market size is anticipated to experience substantial growth in the forthcoming years. It is projected to expand to $10.64 billion by 2030, driven by a compound annual growth rate (CAGR) of 30.4%. This expansion during the forecast period can be attributed to the integration of machine learning and AI in risk stratification, increased adoption among healthcare providers and payers, the proliferation of cloud-based risk stratification solutions, a rising demand for real-time clinical decision support, and the expansion of population health management initiatives. Significant trends expected during this period include the increasing adoption of AI-based risk prediction models, a rising deployment of cloud-based risk stratification platforms, growing integration of risk stratification with clinical workflows, an increasing focus on real-time patient risk monitoring, and a rising utilization of data analytics for population health management.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20917&type=smp
Which Growth Drivers Are Contributing To The Progress Of The Patient Risk Stratification Market?
The increasing prevalence of chronic illnesses is anticipated to drive expansion within the patient risk stratification market in the foreseeable future. These are enduring health conditions, typically lasting for at least three months. This escalating burden stems from factors such as an aging demographic, poor lifestyle choices, increased urbanization, environmental influences, restricted access to healthcare, socioeconomic inequalities, and elevated stress. By classifying individuals according to their varying risk levels for chronic diseases, patient risk stratification enables tailored care, timely interventions, more efficient allocation of resources, and ultimately better health results. For example, in June 2025, the World Health Organization, a global specialized agency based in Switzerland, reported that noncommunicable diseases (NCDs) continue to be the primary cause of mortality and disability globally, particularly within the WHO European Region. In this region, NCDs like cardiovascular diseases, cancers, chronic respiratory ailments, and diabetes lead to the deaths of 1 in 5 men and 1 in 10 women before they reach 70 years of age. Consequently, the increasing prevalence of chronic diseases acts as a key driver for the patient risk stratification market.
What Major Segment Divisions Exist Within The Patient Risk Stratification Market?
The patient risk stratification market covered in this report is segmented –
1) By Type: Predictive Risk Stratification Model, Retrospective Risk Stratification Model, Prospective Risk Stratification Model, Concurrent Risk Stratification Model
2) By Component: Software, Services
3) By Delivery Model: On-Premise, Cloud-Based
4) By Application: Risk Adjustment, Clinical Workflow, Revenue Cycle Management, Other Applications
5) By End User: Healthcare Providers, Healthcare Payers, Other End Users
Subsegments:
1) By Predictive Risk Stratification Model: Machine Learning-Based Predictive Models, Statistical Predictive Models, AI-Powered Predictive Models
2) By Retrospective Risk Stratification Model: Historical Data-Based Risk Models, Data Mining Retrospective Models
3) By Prospective Risk Stratification Model: Longitudinal Cohort-Based Models, Real-Time Risk Assessment Models
4) By Concurrent Risk Stratification Model: In-Hospital Risk Assessment Models, Real-Time Clinical Decision Support Models
Which Trends Are Shaping The Future Of The Patient Risk Stratification Market?
Leading companies within the patient risk stratification market are concentrating on technological advancements in healthcare, particularly artificial intelligence (AI) in disease screening. This focus aims to improve early detection, enhance patient outcomes, and lower healthcare costs by enabling more precise risk assessments and individualized treatment plans. AI in disease screening leverages sophisticated algorithms and machine learning to analyze medical data, allowing for early disease identification and better diagnostic accuracy through rapid processing of extensive information. For instance, in May 2024, WELL Health Technologies Corporation, a Canada-based healthcare company, and its investee company HEALWELL AI, a Canada-based healthcare company focused on AI and data science for preventative care, introduced WELL AI Decision Support (WAIDS). Initially targeting rare diseases, this system now also screens for chronic conditions such as kidney disease, hypertension, and diabetes. It possesses the capability to detect over 100 diseases and offers risk stratification, thereby assisting clinicians in identifying care gaps and accessing actionable data at the point of care.
Which Companies Are Leading Innovation In The Patient Risk Stratification Market?
Major companies operating in the patient risk stratification market are NextGen Healthcare Inc., Health Catalyst, Freenome, Strive Health, Medeanalytics Inc., Lightbeam Health Solutions, Graphnet Health Ltd., Equipo Health Inc., Epic Systems Corporation, Cerner Corporation, IBM Corporation, Allscripts Healthcare Solutions Inc., Medecision Inc., Cotiviti Inc., SAS Institute Inc., SCIO Health Analytics, Arcadia io, HealthEC LLC, Conifer Health Solutions LLC, Wellcentive Inc., ZeOmega Inc., LexisNexis Risk Solutions, Milliman Inc., NVision Health, RLDatix, Verisk Analytics Inc., Innovaccer Inc., eClinicalWorks, Enli Health Intelligence, Athenahealth Inc., i2i Population Health, 3M Health Information Systems, Change Healthcare, Cognizant Technology Solutions, McKesson Corporation, Evolent Health Inc.
Read the full patient risk stratification market report here:
https://www.thebusinessresearchcompany.com/report/patient-risk-stratification-global-market-report
What Are The Leading Geographic Regions In The Patient Risk Stratification Market?
North America was the largest region in the patient risk stratification market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the patient risk stratification market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Patient Risk Stratification Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=20917&type=smp
Browse Through More Reports Similar to the Global Patient Risk Stratification Market 2026, By The Business Research Company
Healthcare Compliance Software Global Market Report
Medical Software Global Market Report
https://www.thebusinessresearchcompany.com/report/medical-software-global-market-report
Personal Health Record Software Global Market Report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
